Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Saad Shakir

Psychiatry San Jose, CA Medical Doctor

NPI 1245367374 CMS profile 282920

2039 Forest Ave Ste 201, San Jose, CA 95128

Open in the dashboard

General payments

$66,377

828 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Saad Shakir of San Jose, CA is reported in the CMS Open Payments database as having received $66,377 across 828 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $19,777 165
2021 General $7,077 210
2020 General $13,138 156
2019 General $26,385 297

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Saad Shakir
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Saad Shakir were reported at $0. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Saad Shakir Psychiatry median Middle half National median
2019 $26,385 $184 $59–$605 $163
2020 $13,138 $119 $36–$372 $114
2021 $7,077 $143 $43–$576 $132
2022 $19,777 $153 $50–$590 $149
2023 $0 $170 $56–$651 $160
2024 $0 $179 $57–$673 $164
2025 $0 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Janssen Pharmaceuticals, Inc $28,226 136 payments
  2. Ironshore Pharmaceuticals Inc. $24,184 89 payments
  3. Takeda Pharmaceuticals U.S.A., Inc. $1,696 83 payments
  4. Neurocrine Biosciences, Inc. $1,382 67 payments
  5. Sunovion Pharmaceuticals Inc. $1,244 75 payments
  6. Lundbeck LLC $1,207 73 payments
  7. Brainsway USA Inc $1,075 2 payments
  8. Otsuka America Pharmaceutical, Inc. $1,028 65 payments
  9. Teva Pharmaceuticals USA, Inc. $975 36 payments
  10. ITI, Inc. $881 33 payments
  11. Other $4,478 169 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $42,060 24 payments
  2. Food and Beverage $17,194 749 payments
  3. Travel and Lodging $5,828 42 payments
  4. Consulting Fee $1,000 1 payment
  5. Education $295 12 payments
Products named General payments · program years 2019–2022
  1. SPRAVATO $27,504 106 payments
  2. Jornay PM 20mg capsules (Bottle of 100) $13,837 53 payments
  3. JORNAY PM $10,347 36 payments
  4. LATUDA $1,244 75 payments
  5. TRINTELLIX $1,234 59 payments
  6. INVEGA SUSTENNA $1,115 46 payments
  7. BrainsWay Deep TMS $1,075 2 payments
  8. CAPLYTA $881 33 payments
  9. REXULTI $860 53 payments
  10. NEUROSTAR TMS THERAPY SYSTEM $770 2 payments
  11. Other $10,111 474 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

828 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record